Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are two of the most valuable healthcare stocks in the world, largely due ...

Researchers have linked herpes simplex virus-1 with Alzheimer's disease, revealing a surprising potential viral trigger for the neurodegenerative condition. Their study suggests that the tau protein, ...

A recent study by Tufts and Oxford universities reveals that head trauma can activate dormant herpes viruses in the brain, ...

The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...

Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to posdinemab, a phosphorylated tau-directed monoclonal antibody (mAb) ...

A new study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...

As Lamborn prepares to leave office, we are most grateful for his support. His support of these signed bills advances the ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

China is expected to witness the highest prevalence with an estimated 10.4 million cases. The total prevalent cases of ...